Inventor
Wei Zhou
Inventor
Scotch Plains, NJ, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds5%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C07BGeneral methods of organic chemistry3%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,759,765Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute202010,759,805Compounds that are ERK inhibitors202010,640,476Bicyclic heteroaryl derivatives and preparation and uses thereof202010,626,077Salvianolic acid compound T, preparation method therefor, and use thereof202010,500,577Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides201910,344,039Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use201910,214,512Factor XIA inhibitors201910,065,967Compounds that are ERK inhibitors20189,827,290Compositions and methods relating to induction of intestinal stem cell homeogenesis and/or regeneration20179,745,307'Compounds that are ERK inhibitors'20179,676,780'Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties'20179,670,213'Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor'20179,290,454'Substituted isoquinolines as CRTH2 receptor modulators'20169,233,979'Compounds that are ERK inhibitors'20169,226,922'Compounds that are ERK inhibitors'20169,023,865'Compounds that are ERK inhibitors'20158,927,559'Quinazolinone-type compounds as CRTH2 antagonists'20158,673,900'Gamma secretase modulators'20148,598,158'Fused tricyclic compounds for the treatment of inflammatory disorders'20138,591,908'Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis B and the producing method and use thereof'20138,592,383'Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators'20138,518,975'Gamma secretase modulators'20138,450,343'Gamma secretase modulators'20137,638,531'Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists'20096,333,152'Gene expression profiles in normal and cancer cells'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2020Based in Scotch Plains, NJ, US· patent location history
2013–2020Patents assigned to MERCK SHARP & DOHME (15)· patent assignee history
2013–2019Patents assigned to ZHOU WEI (10)· patent assignee history
2013–2017Patents assigned to HUANG XIANHAI (8)· patent assignee history
2013–2015Patents assigned to PALANI ANANDAN (6)· patent assignee history
2013–2015Patents assigned to ASLANIAN ROBERT G (5)· patent assignee history
2017–2020Based in Shanghai, CN· patent location history
2017Based in Ann Arbor, MI, US· patent location history
2020Based in Wuhan, CN· patent location history
2020Based in Tianjin, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 15 | 2013–2020 |
| ZHOU WEIself | 10 | 2013–2019 |
| HUANG XIANHAI | 8 | 2013–2017 |
| PALANI ANANDAN | 6 | 2013–2015 |
| ASLANIAN ROBERT G | 5 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Scotch Plains, New Jersey, US | 15 | 2009–2020 |
| Shanghai, CN | 3 | 2017–2020 |
| Wuhan, CN | 1 | 2020 |
| Tianjin, CN | 1 | 2020 |
| Ann Arbor, MI, US | 1 | 2017 |